Detroit, Michigan, has been one the hardest hit regions with a large number of COVID-19 cases. William O’Neill, M.D. ...
Cath Lab
The catheterization lab channel includes content related to interventional technologies for coronary and peripheral artery disease (PAD). Other cath lab transcatheter device technologies covered on this page included percutaneous treatment for stroke, venous interventions, heart valves, hypertension, heart failure and percutenous coronary interventions (PCI).
Here is the list of American College of Cardiology (ACC) practice-changing late-breaking study presentations at the ACC ...
April 9, 2020 — Abbott announced its TriClip Transcatheter Tricuspid Valve Repair (TTVR) System has received European CE ...
Venous thromboembolism (VTE), and pulmonary embolism (PE) in particular, are among the most complex and dangerous acute ...
April 7, 2020 — Boston Scientific Corp. is recalling its Imager II 5 French angiographic catheters, because there is a ...
April 7, 2020 — The U.S. Food and Drug Administration (FDA) has issued guidance to provide a policy to help expand the ...
April 6, 2020 — Here is the list of the most popular content on the Diagnostic and Interventional Cardiology (DAIC) maga ...
Adjustable parameters on the ACIST® CVI® Contrast Delivery System include, flow rate, volume, pressure limit, rise time ...
April 3, 2020 — The Society for Cardiovascular Angiography and Interventions (SCAI) and the Canadian Association of ...
Basel Ramlawi, M.D., chairman of The Heart and Vascular Center at Valley Health System in Virginia, director of the ...
A new year — and decade — offers the opportunity to reflect on the advancements and challenges of years gone by and ...
As medical advancements continue to push the boundaries of what is possible in the field of structural heart ...
April 1, 2020 — Three months after undergoing renal denervation (RDN), patients with untreated high blood pressure had ...
April 1, 2020 — Three months after undergoing renal denervation (RDN), patients with untreated high blood pressure had ...
A review of the PARTNER 3 Low-Risk Trial with Michael Mack, M.D., chairman, cardiovascular service line, Baylor Scott ...
While the current positive revolution in percutaneous coronary intervention (PCI) practice has been made possible by the ...
March 30, 2020 — Edwards Lifesciences Corp. announced it is temporarily pausing new enrollments in its active pivotal ...
March 30, 2020 — Patients in the United Kingdom (U.K.) who underwent transcatheter aortic valve replacement (TAVR) did ...
March 30, 2020 — Low-risk patients undergoing transcatheter aortic valve repair (TAVR) at two years did just as well ...
April 10, 2020